Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2000
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/20/2000CN1277550A Modified release multiple-units compositions of non-steroid anti-inflammatory drug sbstances (NSAIDS)
12/20/2000CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them
12/20/2000CN1277032A Plaster for dispelling wind-evil and wetness-evil and stopping pain
12/20/2000CN1059596C 搽剂 Liniment
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162829 (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
12/19/2000US6162808 Compounds
12/19/2000US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors
12/19/2000US6162790 Oligopeptides
12/19/2000CA2189527C Novel elastase inhibitors
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/19/2000CA2014759C Novel steroid derivatives
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075144A2 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075127A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000075117A1 Compositions and methods for inhibiting cell death
12/14/2000WO2000075116A2 Tricyclic analgesics
12/14/2000WO2000075113A1 Novel heterocyclic carboxamide derivatives
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074703A2 Therapeutic agent comprising a botulinum neurotoxin
12/14/2000WO2000074699A1 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
12/14/2000WO2000074695A2 Tanacetum parthenium extract
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074678A1 Analgesics
12/14/2000WO2000074670A1 USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON β-GLUCURONIDASE IN HUMAN TISSUE
12/14/2000WO2000074662A2 Arthritis treatment
12/14/2000WO2000074651A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
12/14/2000WO2000063208B1 Substituted imidazoles, their preparation and use
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000044763A3 Compositions for treating inflammatory response
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000DE19926475A1 Träger-Pharmaka-Konjugate Carrier conjugates drugs
12/14/2000DE19925810A1 Anwendung von Verapamil und Verapamilderivaten zur Herstellung von Arzneimitteln mit Glucuronidase hemmender Wirkung Application of verapamil and Verapamilderivaten for producing drugs with glucuronidase inhibiting action
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2390948A1 Cell adhesion-inhibiting antiinflammatory compounds
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376199A1 Use of verapamil and verapamil derivatives for producing medicaments with an inhibiting effect on .beta.-glucuronidase in human tissue
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376076A1 Tricyclic analgesics
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375843A1 Compositions and methods for inhibiting cell death
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2373336A1 Peroxynitrite decomposition catalysts and methods of use thereof
12/14/2000CA2370013A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
12/13/2000EP1059302A1 Factor VIIa inhibitors
12/13/2000EP1059092A1 Use of complexes among cationic liposomes and polydeoxyribonucleotides as medicaments
12/13/2000EP1059089A1 Preventives/remedies for inflammatory intestinal disease
12/13/2000EP1059084A2 Rapidly absorbed liquid compositions containing an amine and a NSAID
12/13/2000EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
12/13/2000EP1058698A1 Preparation for prevention and healing of inflammation affections
12/13/2000EP1058692A1 Pf4 fragments and pharmaceutical compositions containing same
12/13/2000EP1058682A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
12/13/2000EP1058561A1 Solubilizing delivery systems and method of manufacture
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP0749438B1 Novel silyl compounds and their use
12/13/2000CN1276797A Low-toxicity human interferon-alpha analog
12/13/2000CN1276784A Cyclic amino acids and derivs. thereof useful as pharmaceutical agents
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276721A Use of 6,7-substd. 2-aminotetralines suitable for preparing pharmaceutical composition for therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276218A Secondary dissolving-in method for preparing 'Zhuifeng Zhentong' plaster for alleviating pain
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1276205A Turmeric as antiirritant in composition contg. hydroxy acid or retinene derivs.
12/12/2000US6160175 Naphthyl acetamides as sPLA2 inhibitors
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160019 Dissolving 0.1 to 10% w/v of nimesulide in 2 to 90% w/v of dimethylacetamide to form a solution, adding benzyl alcohol, polyethylene glycol, hydrochloric acid, propylene glycol
12/12/2000US6160012 Leukotriene B4 derivatives, in particular oximo-LTB4 - antagonists
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/12/2000US6159964 Vitronectin receptor antagonists
1 ... 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 ... 1272